Aktiesnakken — November 2009
-
stort lager af egfr
-
der er taget et number of steps for at valuere fabrikken
-
outside independent experts
-
det er en estimates
-
300 ansatte - broadly giv os en ide hvem der bliver ramt
-
timingen af salget
-
mange fra r&d. 130 ryger fra fabrikken
-
110 primarily i R&D og close UK sites + Dutch facility
-
gennemsnitsløn i genmab er 750K!
-
focus going forward R&D
-
hvormange arbejder med arzerra...
-
aka, er det dig man kan høre der chatter ibaggrunden på tastaturet...
-
-
mest costeffective at GSK kører forsøgene
-
studierne winder ned, og gsk tager de nye studier
-
ingen genmab folk i de nye data, det er GSK, og det er according to plan
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind